Skip to content

The Effect of Flower Extract of Elaeagnus Angustifolia on Sexual Functioning in Menopausal Women

The Effect of Flower Extract of Elaeagnus Angustifolia on Sexual Functioning in Menopausal Women

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100124003146N12
Enrollment
68
Registered
2023-11-13
Start date
2023-11-21
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual function. Symptomatic premature menopause

Interventions

Intervention 1: Intervention group: In this study, the hydroalcoholic extract of elderflower will be prepared in Asha Medicinal Herbs Trading Company, which will be purchased after the approval of the

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: being married Being Iranian Getting a score of less than 28 on the questionnaire on women's sexual performance index over 55 years old Having regular sex with your spouse Menopause diagnosed by a gynecologist No history of uterine or breast cancer Not being treated with chemotherapy or radiotherapy

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Taking antidepressants or drugs related to sexual performance having cognitive impairment based on the MMSE questionnaire (cutoff point 19) Having a medical prohibition to have sex for the spouse, such as heart attacks or heart failure A person suffering from chronic and active diseases that prevent sexual intercourse Hormone therapy (estrogen, progesterone, testosterone) in the last month

Design outcomes

Primary

MeasureTime frame
The sexual performance score of postmenopausal women is less than 28 from the FSFI questionnaire. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention (35 days), one month after the end of the intervention. Method of measurement: Female Sexual Function Index.

Secondary

MeasureTime frame
Anxiety. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention, one month after the end of the intervention. Method of measurement: Beck Anxiety Inventory.;Sleep quality. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention, one month after the end of the intervention. Method of measurement: Pittsburgh Sleep Quality Index.;Number of times of intercourse per month. Timepoint: At the beginning of the study (before the start of the intervention), the end of the intervention, one month after the end of the intervention. Method of measurement: Questionnaire (one question about the number of sexual intercourses per month).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIsmail Azizi Fini

Kashan University of Medical Sciences

azizi-es@kaums.ac.ir+98 36 1555 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026